Working together to support health and medical research

Despite this significant investment, NHMRC receives more research proposals each year than it is able to fund. Many of these are high quality and well-suited to funding through third parties. 

The following sections outline how you can work with NHMRC in funding health and medical research, along with the benefits of doing so.

For further information contact SupportingResearch@nhmrc.gov.au 

Making the most of your support

Providing funding for health and medical research (whether via a donation, bequest, grant or other means) is a simple and direct way of contributing to advances in our understanding and improvement of health. However, determining which project, researchers or institution to support can be challenging. Running your own grant program can also be time-consuming and costly.

Note: To access a tax deduction, potential partners could support health and medical research through charitable organisations. 

How NHMRC can help

NHMRC is uniquely positioned to work with individuals, philanthropic trusts and foundations, government agencies and other funders to effectively and efficiently direct funds by drawing on NHMRC’s expertise and services.

Specific benefits include:

• reputation and experience:
  • NHMRC is Australia’s largest health and medical research funding body with over 80 years of experience supporting the health and medical research sector.
• opportunities to support a variety of research areas and institutions, in line with your objectives:
  • NHMRC supports research across the full spectrum of health and medical research, from basic science through to clinical, public health and health services research.
  • Funds can be distributed to researchers at approved universities, medical research institutes and hospitals through existing or custom grant programs. NHMRC can help with identifying suitable recipients. Many of these entities have deductible gift recipient (DGR) status.
  • Custom programs can be designed to support a broad range of research including: research on a specific disease, career development, large collaborative research programs or focused projects, partnerships with the health industry and policy makers, development of ideas with commercial potential, and international collaborative research, amongst others.
• well-established, rigorous peer review processes:
  • NHMRC utilises expert peer reviewers to evaluate applications and identify the best research proposals and researchers.
• time and cost savings:
  • NHMRC’s grant application, assessment and administration processes can be used as an alternative to developing and running your own systems.
• expertise drawn from all areas of the health system, including:
  • governments, medical practitioners, nurses and allied health professionals, research institutions, public and private program managers, service administrators, community health organisations and consumers.

NHMRC’s Policy on Recognition of Supporting Partners

NHMRC’s Policy on Recognition of Supporting Partners acknowledges the role of Partners who work with NHMRC to support health and medical research. It sets out a strategy to recognise current and potential NHMRC Partners and how Partners recognise NHMRC.

Key considerations

There are a number of other factors to consider when providing funding to health and medical research. Apart from defining your objectives, it is important to be clear about:

• the total amount of funding you wish to make available 
• the duration of your commitment
• whether you want to make a one-off or recurring contribution.

In funding health and medical research what do you wish to achieve?

• Build capacity in an area of research interest
• Support excellence in an area of research interest
• Support a specific research area.

Funding pathways

NHMRC offers a range of funding pathways, depending on your objectives, funding amount, timeframes and other preferences. A Partnering Decision Tree presents potential partners with options to assist in making a decision on the type of funding model to adopt (see downloads below). 

Some common approaches together with their key characteristics are outlined below.

1. Support a specific research project in partnership with researchers

Key characteristics:

• Organisations involved with health care policy and service delivery can partner with researchers on a specific NHMRC grant application under NHMRC’s Partnership Projects scheme.
• Support for the project provided by a funder can be in the form of cash and/or in-kind (non-monetary goods and services) contributions.
• Prospective funders have the opportunity to shape the research question and leverage additional NHMRC funding.
• Examples of partners who use this approach are listed on the Partnership Projects website, under the heading 'Outcomes of funding rounds'.
• Indicative timeframe from inception to award: 6 to 9 months.

Case study:

1A. Funded through an NHMRC Partnership Grant, the Cancer Data and Aboriginal Disparities (CanDAD) project aimed to improve cancer diagnosis, treatment and outcomes for Aboriginal Australians. Supporters of this research included the University of South Australia, the South Australian Health and Medical Research Institute, S.A. Department of Health and Ageing, Cancer Council S.A., the Aboriginal Health Council of South Australia, and BreastScreen S.A. In addition to financial assistance, supporters provided in-kind contributions such as population datasets, strategic advice, research development, industry insight, written publications and expertise.

2. Support an existing NHMRC grant program

Key characteristics:

• Suited to prospective funders whose interests (e.g. career development or research into a specific disease or condition) align with the objectives of an existing NHMRC scheme.
• Options include:
  • Co-funding — your funds are pooled with NHMRC’s funds to provide increased support for the next round of an existing program. NHMRC can manage all aspects of the funding cycle from application through to award (see Case Study 2A). You could be named as a co-funder and publicise the grants, alongside NHMRC. Indicative timeframe from inception to award: 9 to 18 months.
  • Gap funding — NHMRC can supply you with a list of high quality applications following NHMRC peer review, which exceed NHMRC’s budget to fund. You can then choose what research or researchers to fund and at what level, as well as administer the grants if you wish (see Case Study 2B). Indicative timeframe from inception to award: 3 to 6 months.
  • Top-up funding — you can separately provide funds to successful applicants in addition to the funds NHMRC has awarded. NHMRC administers the core grant and you are responsible for administration of the ‘top-up’ funding (see Case Study 2C).

Case studies:

2^A. The Department of Health has partnered with NHMRC to boost the scale of three NHMRC fellowships schemes, with NHMRC conducting the peer review and grant administration and the Department contributing funds from the Medical Research Future Fund. Further details: Department of Health website.

2^B. Cancer Councils and Cancer Australia have partnered with NHMRC’s Ideas Grants and Clinical Trials and Cohort Studies schemes (and former Project Grants scheme) to fund researchers investigating the causes, treatment and prevention of cancer who are assessed as fundable, but will not be funded by NHMRC. Further details: Cancer Council and Cancer Australia websites.

2^C. In their shared support of young clinical researchers, the Royal Australasian College of Physicians (RACP) has partnered with NHMRC to provide “top-up” funds to select recipients of NHMRC Postgraduate Scholarships. Through a number of supplementary Awards of Excellence, RACP grants an additional $10,000 per annum, for up to three years. Further details: Royal Australasian College of Physicians website.

3. Co-design a grant program with NHMRC to address a specific issue

Key characteristics:

• A very flexible funding model, which can be tailored to your specific needs.
• You can work with NHMRC in developing a one-time (e.g. Targeted Call for Research (3A) or Joint Call for Research (3B)) or recurring (e.g. annual scholarship) call for grant applications to address a specific health issue that aligns with NHMRC’s mission.
• This may include assisting in specifying the scope and objectives of the research, application requirements and procedures, and the review criteria to be applied, and participating in the peer review.
• Overseas funders should refer to NHMRC’s International Engagement Strategy for other relevant considerations.
• Indicative timeframe from inception to award: 9 to 18 months.

Case studies:

3^A. beyondblue has partnered with NHMRC to design and co-fund a Targeted Call for Research into depression, anxiety and suicide among elderly Australians. beyondblue is also working with NHMRC in a co-funding arrangement in childhood adversity under the Centres of Research Excellence scheme.

3^B. The National Natural Science Foundation of China (NSFC) entered into an agreement with NHMRC to run a Joint Call for Research to Enhance Prediction and Improve the Treatment of Type 2 Diabetes in China and Australia. This included establishing a joint panel for the review of applications and co-funding supported projects.

4. Use NHMRC systems and processes to support your own grant program

Key characteristics:

• Allows you to benefit from NHMRC’s well-established application and rigorous peer review processes (note: NHMRC may seek to recover costs of providing services from Government entities).
• You retain responsibility for, and control over, all other program elements (e.g. objectives, eligibility, review criteria, funding decisions, grant administration, publicity, branding, announcements).
• Indicative timeframe from inception to award: 3 to 9 months.

Case study:

4^A. In 2016, the Department of Foreign Affairs and Trade (DFAT) partnered with NHMRC to align the NHMRC’s Northern Australia Tropical Disease Collaborative Research Program with the DFAT Tropical Disease Research Regional Collaboration Initiative. This arrangement allowed applicants to apply for separate funding from DFAT under the Tropical Disease Research Regional Collaboration Initiative, using NHMRC’s application processes. NHMRC conducted the peer review of applications on behalf of DFAT to identify applications suitable for their funding. Details, including peer review outcomes, of all applications that were considered fundable and relevant to DFAT objectives were provided to DFAT.  The decision to award DFAT funding, and grant administration, remained the responsibility of DFAT. 

5. Support health and medical research through a non-specific gift or bequest

• In addition to the pathways listed above, individuals and organisations can support NHMRC’s activities by making a donation or nominating NHMRC as a beneficiary in their final testament.[1] These can be made to support specific types of research or given unconditionally, depending on your preference. All gifts must be in accord with NHMRC’s functions, policies and abilities, and are subject to formal acceptance by NHMRC.
• Gifts and bequests received by NHMRC are placed in our Medical Research Endowment Account (MREA) for the purposes of the MREA (i.e. in order to provide assistance to institutions and people engaged in medical research and for medical research training), subject to any conditions (Note: unspent funds cannot be returned).
• In the case of unconditional gifts and bequests, expenditure of the MREA is used to support a variety of grant types, including Ideas Grants, Investigator Grants, Development Grants, Partnership Projects, a range of scholarships, Centres of Research Excellence, Targeted Calls for Research and several collaborative schemes with international partners.
• If you are interested in making a gift or bequest, we recommend you seek private legal advice or contact the Public Trustee in the first instance.
   

Opportunities under NHMRC’s grant program

See Overview of NHMRC.

NHMRC’s grant program provides opportunities for individuals, groups and organisations to support health and medical research by:

• funding across the spectrum of health and medical research
• investing in people with outstanding research achievements and promise
• supporting the most innovative research to solve complex problems, and
• meeting specific objectives.

The NHMRC grant program offers a broad range of opportunities that will meet the needs of most prospective supporters. Alternatively, if your needs cannot be met via the four available streams NHMRC can work with you to design a custom call (e.g. the new Strategic and Leveraging Grants stream includes an enhanced Targeted Calls for Research scheme).

[1] Donations or bequests to NHMRC are not tax deductible.